|
Volumn 23, Issue 2 A, 2003, Pages 845-850
|
Atypical courses of serum tumor markers-4 case reports
|
Author keywords
CA 19 9; CA 125; CA 72 4; Cancer; Serum; Tumor markers
|
Indexed keywords
CA 125 ANTIGEN;
CA 19-9 ANTIGEN;
CA 72-4 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
FLUOROURACIL;
GEMCITABINE;
MISTLETOE EXTRACT;
MITOMYCIN C;
OXALIPLATIN;
PEPTIDE DERIVATIVE;
PLANT EXTRACT;
TUMOR MARKER;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ADULT;
AGED;
ASCITES;
BILE DUCT OBSTRUCTION;
BIOASSAY;
BLOOD LEVEL;
CANCER PATIENT;
CASE REPORT;
CAUSE OF DEATH;
CHOLANGITIS;
CONCENTRATION (PARAMETERS);
CONFERENCE PAPER;
DIAGNOSTIC PROCEDURE;
DISEASE COURSE;
DISEASE SEVERITY;
FEMALE;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
LABORATORY TEST;
MALE;
NEUROPATHY;
ONCOLOGY;
PANCREAS CANCER;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RADIODIAGNOSIS;
STOMACH CARCINOMA;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE;
CA-125 ANTIGEN;
CA-19-9 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
FEMALE;
GALLBLADDER NEOPLASMS;
HUMANS;
MALE;
MIDDLE AGED;
PANCREATIC NEOPLASMS;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
STOMACH NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0038538351
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (6)
|
References (6)
|